Correlation Between Gamida Cell and Aldeyra
Can any of the company-specific risk be diversified away by investing in both Gamida Cell and Aldeyra at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gamida Cell and Aldeyra into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Gamida Cell and Aldeyra, you can compare the effects of market volatilities on Gamida Cell and Aldeyra and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gamida Cell with a short position of Aldeyra. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gamida Cell and Aldeyra.
Diversification Opportunities for Gamida Cell and Aldeyra
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Gamida and Aldeyra is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Gamida Cell and Aldeyra in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aldeyra and Gamida Cell is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gamida Cell are associated (or correlated) with Aldeyra. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aldeyra has no effect on the direction of Gamida Cell i.e., Gamida Cell and Aldeyra go up and down completely randomly.
Pair Corralation between Gamida Cell and Aldeyra
If you would invest 502.00 in Aldeyra on December 29, 2024 and sell it today you would earn a total of 165.00 from holding Aldeyra or generate 32.87% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Gamida Cell vs. Aldeyra
Performance |
Timeline |
Gamida Cell |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Aldeyra |
Gamida Cell and Aldeyra Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Gamida Cell and Aldeyra
The main advantage of trading using opposite Gamida Cell and Aldeyra positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gamida Cell position performs unexpectedly, Aldeyra can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aldeyra will offset losses from the drop in Aldeyra's long position.Gamida Cell vs. BioLineRx | Gamida Cell vs. Ardelyx | Gamida Cell vs. Lexicon Pharmaceuticals | Gamida Cell vs. Seres Therapeutics |
Aldeyra vs. Tarsus Pharmaceuticals | Aldeyra vs. Travere Therapeutics | Aldeyra vs. Eton Pharmaceuticals | Aldeyra vs. Viridian Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Equity Valuation Check real value of public entities based on technical and fundamental data |